Skip to content

BACARE TECH: value indication

Line	Code	2021	2025	Change	%
Total assets	20/58	€1,517	€175	-€1,342	-88.5%
Fixed assets	21/28	-	€167	+€167
Intangible fixed assets	21	-	€167	+€167
Current assets	29/58	€1,517	€8	-€1,509	-99.5%
Amounts receivable within one year	40/41	€1,517	-	-€1,517
Other amounts receivable	41	€1,517	-	-€1,517
Cash at bank and in hand	54/58	-	€8	+€8
Total equity and liabilities	10/49	€1,517	€175	-€1,342	-88.5%
Equity	10/15	-€4,531	-€17,611	-€13,081	-289%
Contributions	10/11	€3,000	€3,000	=	0.0%
Capital	10	-	€3,000	+€3,000
Issued capital	100	-	€3,000	+€3,000
Profit (loss) carried forward	14	-€7,531	-€20,611	-€13,081	-174%
Amounts payable	17/49	€6,047	€17,786	+€11,739	+194%
Amounts payable within one year	42/48	€6,047	€17,786	+€11,739	+194%
Other amounts payable	47/48	€6,047	€17,786	+€11,739	+194%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	-	€433	+€433
Other operating charges	640/8	-	€0	=
Gross operating margin	9900	-€7,223	-€5,227	+€1,996	+27.6%
Operating profit (loss)	9901	-€7,223	-€5,660	+€1,563	+21.6%
Financial charges	65/66B	€307	€44	-€264	-85.8%
Recurring financial charges	65	€307	€44	-€264	-85.8%
Profit (loss) for the period before taxes	9903	-€7,531	-€5,704	+€1,827	+24.3%
Profit (loss) for the period	9904	-€7,531	-€5,704	+€1,827	+24.3%
Profit (loss) for the period to be appropriated	9905	-€7,531	-€5,704	+€1,827	+24.3%

Position among the sector peers